BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27733957)

  • 1. Factors Associated With Musculoskeletal Injuries in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Guy JA; Knight LM; Wang Y; Jerrell JM
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27733957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM; McIntyre RS; Park YM
    J Clin Psychiatry; 2014 Nov; 75(11):e1278-83. PubMed ID: 25470092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for incident major depressive disorder in children and adolescents with attention-deficit/hyperactivity disorder.
    Jerrell JM; McIntyre RS; Park YM
    Eur Child Adolesc Psychiatry; 2015 Jan; 24(1):65-73. PubMed ID: 24705730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
    Pullen SJ; Wall CA; Angstman ER; Munitz GE; Kotagal S
    J Clin Sleep Med; 2011 Dec; 7(6):587-96. PubMed ID: 22171196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS; Wang S; Crystal S; Olfson M
    JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
    Davis DW; Feygin Y; Creel L; Kong M; Jawad K; Sun J; Blum NJ; Lohr WD; Williams PG; Le J; Jones VF; Pasquenza N
    J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
    Merrill RM; Thygerson SM; Palmer CA
    Pharmacopsychiatry; 2016 Mar; 49(2):45-50. PubMed ID: 26829453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents.
    Ghirardi L; Larsson H; Chang Z; Chen Q; Quinn PD; Hur K; Gibbons RD; D'Onofrio BM
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):944-951. PubMed ID: 31302218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders.
    Ghirardi L; Chen Q; Chang Z; Kuja-Halkola R; Skoglund C; Quinn PD; D'Onofrio BM; Larsson H
    J Child Psychol Psychiatry; 2020 Feb; 61(2):140-147. PubMed ID: 31625605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs.
    Karic S; DesRosiers M; Mizrahi B; Zevallos J; Rodriguez P; Barengo NC
    Child Care Health Dev; 2019 Sep; 45(5):688-693. PubMed ID: 31049988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
    Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
    Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder.
    Perwien A; Hall J; Swensen A; Swindle R
    J Manag Care Pharm; 2004; 10(2):122-9. PubMed ID: 15032561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
    Liu YC; Chen VC; Yang YH; Chen YL; Gossop M
    Epidemiol Psychiatr Sci; 2021 Feb; 30():e14. PubMed ID: 33583471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I; Lee MS; Lee EK; Shin JY
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Differentiating Childhood-Onset and Adolescent-Onset Schizophrenia:A Claims Database Study.
    Jerrell JM; McIntyre RS
    Prim Care Companion CNS Disord; 2016; 18(2):. PubMed ID: 27486543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.